|

monoclonal antibodies GD2 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 3: 1

Top Sponsors

  • Federal Research Institute of Pediatric Hematology, Oncology and Immunology1

Indications

  • Ganglioneuroblastoma1
  • Neuroblastoma1
  • Cancer1

Other1 trial

Induction Chemoimmunotherapy for Patients With High-risk Neuroblastoma
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.